Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01022892
Other study ID # 2007607-01H
Secondary ID
Status Completed
Phase N/A
First received November 26, 2009
Last updated March 5, 2012
Start date September 2009
Est. completion date March 2012

Study information

Verified date March 2012
Source Ottawa Hospital Research Institute
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

The purpose of this study is to support the suspected expectation that Contrast enhanced Ultrasound (CUS) detects all endoleaks that have been detected by Computed Tomography (CT), and also find a number of leaks missed by CT.

The investigators' primary goal is to detect no difference between CT and CUS and provide evidence that CUS is a possible alternative to CT.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date March 2012
Est. primary completion date March 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- All patients who underwent EVAR at The Ottawa Hospital and currently under post-EVAR surveillance at The Ottawa Hospital.

Exclusion Criteria:

- Unable to consent for injection of contrast

- Unable to acquire IV access

- Right-to-left, bi-directional, or transient right-to-left cardiac shunts

- Severe pulmonary disease

- Previous hypersensitivity to DEFINITY® or its components

- Unable to be followed as a outpatient by the Vascular Diagnostic Center

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ottawa Hospital Research Institute
See also
  Status Clinical Trial Phase
Recruiting NCT03993496 - Intraoperative Assessment of Pulsatile Aneurysm Wall Motion During Endovascular Aneurysm Repair